tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

REGN Stock Latest News

Regeneron price target lowered to $1,081 from $1,150 at Morgan Stanley
The FlyRegeneron price target lowered to $1,081 from $1,150 at Morgan Stanley
19h ago
REGN
Regeneron Faces Financial Challenges Amid Co-Pay Assistance Funding Shortfall, Prompting Sell Rating
PremiumRatings
Regeneron Faces Financial Challenges Amid Co-Pay Assistance Funding Shortfall, Prompting Sell Rating
21h ago
REGN
Regeneron price target lowered to $925 from $950 at Oppenheimer
PremiumThe Fly
Regeneron price target lowered to $925 from $950 at Oppenheimer
7d ago
REGN
Needham healthcare analysts hold analyst/industry conference call
PremiumThe Fly
Needham healthcare analysts hold analyst/industry conference call
8d ago
JNJ
NVS
Gilead, Regeneron have most theoretical PDUFA date risk, says BofA
PremiumThe Fly
Gilead, Regeneron have most theoretical PDUFA date risk, says BofA
8d ago
MRK
GILD
Optimistic Long-Term Growth for Regeneron Amid Near-Term Challenges
PremiumRatingsOptimistic Long-Term Growth for Regeneron Amid Near-Term Challenges
8d ago
REGN
Marks’ Resignation Is a ‘Blow for Biotech Industry,’ Says RBC Analyst as Biotech Stocks Fall
Premium
Market News
Marks’ Resignation Is a ‘Blow for Biotech Industry,’ Says RBC Analyst as Biotech Stocks Fall
9d ago
GILD
LEGN
Biotech stocks slide as Marks resignation seen being negative for sector
Premium
The Fly
Biotech stocks slide as Marks resignation seen being negative for sector
10d ago
DYN
MGX
Marks resignation ‘not good’ for biotech sector, says RBC
PremiumThe Fly
Marks resignation ‘not good’ for biotech sector, says RBC
10d ago
DYN
RNA
Regeneron price target lowered to $1,000 from $1,100 at JPMorgan
PremiumThe Fly
Regeneron price target lowered to $1,000 from $1,100 at JPMorgan
10d ago
REGN
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
13d ago
PTN
SNY
Regeneron, Sanofi announce Dupixent authorization in Japan
PremiumThe Fly
Regeneron, Sanofi announce Dupixent authorization in Japan
13d ago
SNY
REGN
Biotech Alert: Searches spiking for these stocks today
PremiumThe FlyBiotech Alert: Searches spiking for these stocks today
14d ago
ALLR
ALNY
Regeneron: Positioned for Growth Amidst Challenges with a Promising Pipeline and Catalyst-Rich Future
Premium
Ratings
Regeneron: Positioned for Growth Amidst Challenges with a Promising Pipeline and Catalyst-Rich Future
27d ago
REGN
BMO says Eylea court decision ‘modest negative’ for Regeneron
Premium
The Fly
BMO says Eylea court decision ‘modest negative’ for Regeneron
27d ago
AMGN
REGN
Eylea biosimilar injunction denial ‘negative’ for Regeneron, says UBS
PremiumThe Fly
Eylea biosimilar injunction denial ‘negative’ for Regeneron, says UBS
27d ago
REGN
Appeals court upholds denial of Regeneron motion for injunction against Amgen
PremiumThe Fly
Appeals court upholds denial of Regeneron motion for injunction against Amgen
27d ago
AMGN
REGN
Regeneron down 3% after appeals court decision in Amgen patent fight
PremiumThe Fly
Regeneron down 3% after appeals court decision in Amgen patent fight
27d ago
AMGN
REGN
Regeneron, Sanofi presents results from ADEPT Phase 2/3 trial on Dupixent
PremiumThe Fly
Regeneron, Sanofi presents results from ADEPT Phase 2/3 trial on Dupixent
1M ago
SNY
REGN
Regeneron’s treatment of lipodystrophy granted FDA orphan designation
PremiumThe FlyRegeneron’s treatment of lipodystrophy granted FDA orphan designation
1M ago
REGN
Regeneron announces EMA CHMP adopted positive opinion on linvoseltamab
Premium
The Fly
Regeneron announces EMA CHMP adopted positive opinion on linvoseltamab
1M ago
REGN
3 Best Value Stocks to Buy Now, 2/27/2025, According to Analysts 
Premium
Market News
3 Best Value Stocks to Buy Now, 2/27/2025, According to Analysts 
1M ago
FSLR
MPWR

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >